Tuesday, 18 June 2019

Drug Discovery News

  • GSK shuts phase III studies of Crohn's drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: ChemoCentryx reported that GlaxoSmithKline's (GSK) first-of-four phase III studies, called Shield-1; investigating vercirnon did not achieve the primary endpoint of improvement i...Read more

  • Taiwan develops carbohydrate-based cancer vaccine

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-Yi Wu of the Genomics Research Center (GRC) have developed vaccine ca...Read more

  • Phylogica gets patent to model libraries from protein

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

    Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. This core patent (designated USSN 11/672,419) covers generic methods o...Read more

  • Mesoblast to develop neuro diseases therapies

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies for neurodegenerative diseases. In an update on Mesoblast's strategi...Read more

  • BMS halts Hep C drug administration

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2012

    Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094 (formerly known as INX-189), a nucleotide polymerase (NS5B) inhibito...Read more

  • Starpharma drug targets cancer more effectively

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-docetaxel formulation. In recent animal studies Starpharma's docetaxel form...Read more

  • Eisai, Toyama get marketing approval for iguratimod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to market iguratimod for the treatment of rheumatoid arthritis. Iguratimod, ...Read more

  • Jazz Pharma clocks $208 mn in Q2 2013

    Drug Discovery |  Company results | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

    Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an increase from $124.2 million in the same quarter of 2012. The incre...Read more

  • Charles River to acquire Galapagos at USD 179 mn

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2014

    Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta and BioFocus, European companies in integrated drug discovery servic...Read more

  • Chugai, Nippon Shinyaku tie up for drug development

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co-develop and co-market GA101 (obinutuzumab), the first glycoengineere...Read more

  • EMA recommends MSD's melanoma drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

    Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme's Keytruda (pembrolizumab) as monotherapy for the treatment of adult ...Read more

  • 10 top global pharma firms join hands for drug discovery

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

    Singapore: Ten leading biopharmaceutical companies have formed a non-profit organization to accelerate the development of new medicines. Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-...Read more

  • Nuvilex, Lincoln Park Fund sign $27 mn stock deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2014

    Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, entered into a stock purchase agreement with Linco...Read more

  • Korea to spend $8.9 bn to develop 20 drugs by 2017

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the next five years, and this will be done in collaboration with private loc...Read more

  • Abbott reveals 10-year study data for HUMIRA

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Abbott revealed the results from two long-term, open-label studies, which evaluated the results of HUMIRA (adalimumab) treatment for up to 10 years in patients with long-standing...Read more

  • Edinburgh Univ, Biogen to study neuro diseases

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Experts from University of Edinburgh, UK, and Massachusetts-based biotechnology company Biogen Idec have joined hands to seek greater insight into multiple sclerosis and motor ne...Read more

  • Admedus acquires Genzyme manufacturing site

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2013

    Singapore: Admedus, formerly Allied Healthcare, has signed a share purchase agreement to acquire an established manufacturing site from Genzyme Australasia, a Sanofi company. Admedus recei...Read more

  • AstraZeneca halts development of obesity drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: Palatin Technologies collaboration with AstraZeneca is to be discontinued for the further development of AZD2820, one of the many compounds that were jointly being developed for ...Read more



Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls